Krishna Institute of Medical Sciences (KIMS) has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a consolidated net profit of ₹2,420 million for the fiscal year. Alongside these financial outcomes, the company announced strategic leadership appointments and the re-designation of a key executive, as it prepares for its 24th Annual General Meeting scheduled for August 27, 2026.
Financial Performance Overview
For the financial year ended March 31, 2026, KIMS delivered a strong consolidated performance, achieving a total income of ₹39,308 million and a net profit of ₹2,420 million. The standalone financial results for the same period showed a profit of ₹2,607 million. The company’s auditors have issued an unmodified opinion on these results, confirming the accuracy of the financial reporting for the fiscal year.
Strategic Leadership Appointments
In a move to strengthen its management framework, the Board of Directors has identified and appointed several key Senior Management Personnel, effective May 15, 2026:
- Mr. Sachin Ashok Salvi as Chief Finance Officer.
- Mrs. Nagajayanthi J.R as Company Secretary & Compliance Officer.
- Mr. Bhaskar Reddy R. K as Chief Risk Officer & Chief Internal Audit.
Executive Re-designation
The company also announced the re-designation of Mr. Adwik Bollineni from his role as a Non-Executive Director to Executive Director. This transition follows the recommendation of the Nomination & Remuneration Committee and was approved during the board meeting held on May 15, 2026.
Operational Updates
The Board of Directors has also appointed M/s. Sagar & Associates as the Cost Auditors for the FY 2026-27 to audit the company’s cost records. Additionally, the company has scheduled its 24th Annual General Meeting (AGM) to be held on Thursday, August 27, 2026, where members will review the company’s progress and the recommended remuneration for the newly appointed cost auditors.
Source: BSE
